Skip to content

Costs and effects of orthogeriatric co-management in older patients with an osteoporotic fracture in Belgium

Orthogeriatric co-management vs standard of care: health technology assessment evaluation in older patients with an osteoporotic fracture in Belgium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN26055037
Enrollment
40000
Registered
2023-07-17
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving care for older patients with a fracture Injury, Occupational Diseases, Poisoning

Interventions

Standard of care: Standard of care is defined as surgical care with geriatric expertise available upon active request by the trauma team and includes the comprehensive evaluation of the patient by a g

Sponsors

KU Leuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 75 years and over on the day of admission 2. Admission to a listed Belgian hospital (information on the used care model and consent has been provided by representative medical doctors from listed hospitals) 3. Admission via the emergency department in case of arthroplasty of hip and/or shoulder 4. Reason for admission: major osteoporotic fracture (hip, pelvis, femur, shoulder, forearm, and vertebrae; the selection will be based on RIZIV nomenclature) 5. First admission to Belgian hospital in period: 01/01/2019 - 31/12/2019 (to avoid interference with the COVID-19 pandemic and to ensure full data availability)

Exclusion criteria

Exclusion criteria: 1. Patients below 75 years of age on admission 2. Patients admitted to a Belgian hospital that is not on the list of included hospitals 3. Patients undergoing an arthroplasty of the hip and/or shoulder who were NOT admitted via the emergency department to ensure that a fracture was the reason for admission and treatment

Design outcomes

Primary

MeasureTime frame
1. Effectiveness evaluation: 1.1. Mortality evaluation at 1 year after admission 2. Cost-effectiveness evaluation: 2.1. The survival time within 1 year will be estimated time in days from admission to the hospital 2.2. The costs included will be in-hospital costs (e.g., physiotherapy, imaging, hospitalization) and long-term costs during the first year after discharge (e.g., professional care at home, nursing home) Data will be collected by the Intermutualistic Agency

Secondary

MeasureTime frame
1. Effectiveness evaluation: 1.1. Mortality evaluation at 30 days and 90 days after admission 1.2. The Inpatient length of stay will be the estimated time in days between discharge and admission 1.3. Return to pre-fracture living situation, specified as living at home or in a nursing home and compared to the living situation before admission 1.4. Hospital readmissions and emergency department visits evaluation within 30 and 90 days after discharge Data will be collected by the Intermutualistic Agency

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 9, 2026